-
1
-
-
0037417523
-
Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: A quantitative review of 23 randomised trials
-
Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 2003;361:13-20.
-
(2003)
Lancet
, vol.361
, pp. 13-20
-
-
Keeley, E.C.1
Boura, J.A.2
Grines, C.L.3
-
2
-
-
23844482612
-
Sirolimus-eluting stents vs paclitaxel-eluting stents in patients with coronary artery disease: Meta-analysis of randomized trials
-
Kastrati A, Dibra A, Eberle S, et al. Sirolimus-eluting stents vs paclitaxel-eluting stents in patients with coronary artery disease: meta-analysis of randomized trials. JAMA 2005;294:819-25.
-
(2005)
JAMA
, vol.294
, pp. 819-825
-
-
Kastrati, A.1
Dibra, A.2
Eberle, S.3
-
3
-
-
33847167065
-
Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxeleluting stents in routine clinical practice: Data from a large twoinstitutional cohort study
-
Daemen J, Wenaweser P, Tsuchida K, et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxeleluting stents in routine clinical practice: data from a large twoinstitutional cohort study. Lancet 2007;369:667-78.
-
(2007)
Lancet
, vol.369
, pp. 667-678
-
-
Daemen, J.1
Wenaweser, P.2
Tsuchida, K.3
-
4
-
-
33847259689
-
Drug-eluting stent and coronary thrombosis: Biological mechanisms and clinical implications
-
Luscher TF, Steffel J, Eberli FR, et al. Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications. Circulation 2007;115:1051-58.
-
(2007)
Circulation
, vol.115
, pp. 1051-1058
-
-
Luscher, T.F.1
Steffel, J.2
Eberli, F.R.3
-
5
-
-
17844395445
-
Tirofiban and sirolimus eluting stent vs. abciximab and bare-metal stent for acute myocardial infarction: A randomized trial
-
▶ First randomised trial comparing SES to BMS in primary PCI for STEMI
-
Valgimigli M, Percoco G, Malagutti P, et al. Tirofiban and sirolimus eluting stent vs. abciximab and bare-metal stent for acute myocardial infarction: a randomized trial. JAMA 2005;293:2109-17. ▶ First randomised trial comparing SES to BMS in primary PCI for STEMI.
-
(2005)
JAMA
, vol.293
, pp. 2109-2117
-
-
Valgimigli, M.1
Percoco, G.2
Malagutti, P.3
-
6
-
-
33748702281
-
Sirolimus-eluting versus uncoated stents in acute myocardial infarction
-
▶ First large randomised trial comparing SES to BMS in primary PCI for STEMI
-
Spaulding C, Henry P, Teiger E, et al. Sirolimus-eluting versus uncoated stents in acute myocardial infarction. N Engl J Med 2006;355:1093-104. ▶ First large randomised trial comparing SES to BMS in primary PCI for STEMI.
-
(2006)
N Engl J Med
, vol.355
, pp. 1093-1104
-
-
Spaulding, C.1
Henry, P.2
Teiger, E.3
-
7
-
-
42249090036
-
Comparison of angioplasty with infusion of tirofiban or abciximab and with implantation of sirolimus-eluting or uncoated stents for acute myocardial infarction: The MULTISTRATEGY randomized trial
-
▶ Randomised trial with broad inclusion criteria
-
Valgimigli M, Campo G, Percoco G, et al. Comparison of angioplasty with infusion of tirofiban or abciximab and with implantation of sirolimus-eluting or uncoated stents for acute myocardial infarction: the MULTISTRATEGY randomized trial. JAMA 2008;299:1788-99. ▶ Randomised trial with broad inclusion criteria.
-
(2008)
JAMA
, vol.299
, pp. 1788-1799
-
-
Valgimigli, M.1
Campo, G.2
Percoco, G.3
-
8
-
-
34247849437
-
Randomized trial of sirolimus-eluting stent versus bare-metal stent in acute myocardial infarction (SESAMI)
-
▶ Small randomised trial comparing SES and BMS in primary PCI for AMI
-
Menichelli M, Parma A, Pucci E, et al. Randomized trial of sirolimus-eluting stent versus bare-metal stent in acute myocardial infarction (SESAMI). J Am Coll Cardiol 2007;49:1924-30. ▶ Small randomised trial comparing SES and BMS in primary PCI for AMI.
-
(2007)
J Am Coll Cardiol
, vol.49
, pp. 1924-1930
-
-
Menichelli, M.1
Parma, A.2
Pucci, E.3
-
9
-
-
38749154306
-
Sirolimuseluting stents versus bare-metal stents in patients with STsegment elevation myocardial infarction: 9-month angiographic and intravascular ultrasound results and 12-month clinical outcome results from the MISSION Intervention Study
-
▶ Randomised study with an intravascular ultrasound substudy group
-
van der Hoeven BL, Liem SS, Jukema JW, et al. Sirolimuseluting stents versus bare-metal stents in patients with STsegment elevation myocardial infarction: 9-month angiographic and intravascular ultrasound results and 12-month clinical outcome results from the MISSION Intervention Study. J Am Coll Cardiol 2008;51:618-26. ▶ Randomised study with an intravascular ultrasound substudy group.
-
(2008)
J Am Coll Cardiol
, vol.51
, pp. 618-626
-
-
Van Der Hoeven, B.L.1
Liem, S.S.2
Jukema, J.W.3
-
10
-
-
33748690953
-
Paclitaxel-eluting versus uncoated stents in primary percutaneous coronary intervention
-
▶ First randomised study comparing PES to BMS during primary PCI for STEMI
-
Laarman GJ, Suttorp MJ, Dirksen MT, et al. Paclitaxel-eluting versus uncoated stents in primary percutaneous coronary intervention. N Engl J Med 2006;355:1105-13. ▶ First randomised study comparing PES to BMS during primary PCI for STEMI.
-
(2006)
N Engl J Med
, vol.355
, pp. 1105-1113
-
-
Laarman, G.J.1
Suttorp, M.J.2
Dirksen, M.T.3
-
11
-
-
65649091641
-
Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction trial
-
▶ Large randomised trial comparing PES and BMS during primary PCI for STEMI
-
Stone GW, Lansky AJ, Pocock SJ, et al. Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction trial. N Engl J Med 2009;360:1946-59. ▶ Large randomised trial comparing PES and BMS during primary PCI for STEMI.
-
(2009)
N Engl J Med
, vol.360
, pp. 1946-1959
-
-
Stone, G.W.1
Lansky, A.J.2
Pocock, S.J.3
-
12
-
-
52649151888
-
Drug-eluting or bare-metal stents for acute myocardial infarction
-
▶ Study using data from a high quality registry
-
Mauri L, Silbaugh TS, Garg P, et al. Drug-eluting or bare-metal stents for acute myocardial infarction. N Engl J Med 2008;359:1330-42. ▶ Study using data from a high quality registry.
-
(2008)
N Engl J Med
, vol.359
, pp. 1330-1342
-
-
Mauri, L.1
Silbaugh, T.S.2
Garg, P.3
-
13
-
-
59749103515
-
Mortality following placement of drug-eluting and bare-metal stents for ST-segment elevation acute myocardial infarction in the Global Registry of Acute Coronary Events
-
Steg PG, Fox KA, Eagle KA, et al. Mortality following placement of drug-eluting and bare-metal stents for ST-segment elevation acute myocardial infarction in the Global Registry of Acute Coronary Events. Eur Heart J 2009;30:321-9.
-
(2009)
Eur Heart J
, vol.30
, pp. 321-329
-
-
Steg, P.G.1
Fox, K.A.2
Eagle, K.A.3
-
14
-
-
65249147145
-
Use of drug-eluting stents in acute myocardial infarction: A systematic review and metaanalysis
-
▶ Review and meta-analysis of randomised studies and registries
-
Brar SS, Leon MB, Stone GW, et al. Use of drug-eluting stents in acute myocardial infarction: a systematic review and metaanalysis. J Am Coll Cardiol 2009;53:1677-89. ▶ Review and meta-analysis of randomised studies and registries.
-
(2009)
J Am Coll Cardiol
, vol.53
, pp. 1677-1689
-
-
Brar, S.S.1
Leon, M.B.2
Stone, G.W.3
-
15
-
-
33847741037
-
An analysis of data from studies on sirolimus-eluting stents versus bare-metal stents
-
Spaulding C, Daemen J, Boersma E, et al. An analysis of data from studies on sirolimus-eluting stents versus bare-metal stents. N Engl J Med 2007;356:989-97.
-
(2007)
N Engl J Med
, vol.356
, pp. 989-997
-
-
Spaulding, C.1
Daemen, J.2
Boersma, E.3
-
16
-
-
33748709423
-
Drug-eluting stents in acute myocardial infarction
-
Van de Werf F. Drug-eluting stents in acute myocardial infarction. N Engl J Med 2006;355:1169-70.
-
(2006)
N Engl J Med
, vol.355
, pp. 1169-1170
-
-
Van De Werf, F.1
-
17
-
-
36148983750
-
Prasugrel versus clopidogrel in patients with acute coronary syndromes
-
Wiviott SD, Braunwald E, McCabe CH, et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2007;357:2001-15.
-
(2007)
N Engl J Med
, vol.357
, pp. 2001-2015
-
-
Wiviott, S.D.1
Braunwald, E.2
McCabe, C.H.3
-
18
-
-
60649112469
-
Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): Double-blind, randomised controlled trial
-
TRITON-TIMI 38 Investigators
-
Montalescot G, Wiviott SD, Braunwald E, et al. TRITON-TIMI 38 Investigators. Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial. Lancet 2009;373:723-31.
-
(2009)
Lancet
, vol.373
, pp. 723-731
-
-
Montalescot, G.1
Wiviott, S.D.2
Braunwald, E.3
-
19
-
-
33745960402
-
Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: Results from the PREMIER registry
-
▶ Registry study analysing thienopyridine compliance after primary PCI for STEMI
-
Spertus JA, Kettelkamp R, Vance C, et al. Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry. Circulation 2006;113:2803e9. ▶ Registry study analysing thienopyridine compliance after primary PCI for STEMI.
-
(2006)
Circulation
, vol.113
-
-
Spertus, J.A.1
Kettelkamp, R.2
Vance, C.3
-
20
-
-
54949142220
-
Cardiovascular outcomes after a change in prescription policy for clopidogrel
-
Jackevicius CA, Tu JV, Demers V, et al. Cardiovascular outcomes after a change in prescription policy for clopidogrel. N Engl J Med 2008;359:1802e10.
-
(2008)
N Engl J Med
, vol.359
-
-
Jackevicius, C.A.1
Tu, J.V.2
Demers, V.3
|